Cargando…

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial

IMPORTANCE: Tourette syndrome is a neurodevelopmental disorder characterized by childhood onset of motor and phonic tics, often accompanied by behavioral and psychiatric comorbidities. Deutetrabenazine is a vesicular monoamine transporter 2 inhibitor approved in the US for the treatment of chorea as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coffey, Barbara, Jankovic, Joseph, Claassen, Daniel O., Jimenez-Shahed, Joohi, Gertz, Barry J., Garofalo, Elizabeth A., Stamler, David A., Wieman, Maria, Savola, Juha-Matti, Gordon, Mark Forrest, Alexander, Jessica K., Barkay, Hadas, Harary, Eran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524312/ https://www.ncbi.nlm.nih.gov/pubmed/34661664 http://dx.doi.org/10.1001/jamanetworkopen.2021.29397

Ejemplares similares

Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study
por: Jankovic, Joseph, et al.
Publicado: (2023)

Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial
por: Jankovic, Joseph, et al.
Publicado: (2021)

Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016)

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
por: Hauser, Robert A., et al.
Publicado: (2022)

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect
por: Schneider, Frank, et al.
Publicado: (2020)

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers
por: Schneider, Frank, et al.
Publicado: (2020)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2017)

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
por: Frank, Samuel, et al.
Publicado: (2022)

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
por: Fernandez, Hubert H., et al.
Publicado: (2017)

On crushing of deutetrabenazine tablets
por: Knebel, Helena, et al.
Publicado: (2021)

The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2023)

Tics and Tourette’s syndrome
por: Mittal, Shivam Om
Publicado: (2020)

Contrasting features between Tourette syndrome and secondary tic disorders
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2023)

Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders
por: Badenoch, James, et al.
Publicado: (2020)

The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers
por: Schneider, F., et al.
Publicado: (2021)

Editorial: Recent advances in understanding Tourette syndrome, tic disorders and functional tics
por: Ludlow, Amanda K., et al.
Publicado: (2023)

Childhood Predictors of Long-term Tic Severity and Tic Impairment in Tourette’s Disorder
por: Ricketts, Emily J., et al.
Publicado: (2022)

GPi Oscillatory Activity Differentiates Tics from the Resting State, Voluntary Movements, and the Unmedicated Parkinsonian State
por: Jimenez-Shahed, Joohi, et al.
Publicado: (2016)

Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics
por: Eapen, Valsamma, et al.
Publicado: (2015)

The Relation Between Attention and Tic Generation in Tourette Syndrome
por: Misirlisoy, Erman, et al.
Publicado: (2014)

Effects of comorbidity on Tourette's tic severity and quality of life
por: Huisman‐van Dijk, Hilde M., et al.
Publicado: (2019)

Tonic Tics in Gilles de la Tourette Syndrome
por: Kaczyńska, Justyna, et al.
Publicado: (2021)

Blocking Tics in Gilles de la Tourette Syndrome
por: Kaczyńska, Justyna, et al.
Publicado: (2021)

Living with tics: Nursing care of pediatric tourette syndrome
por: Lee, Mei-Yin
Publicado: (2022)

What makes tics tick? Insights into Tourette syndrome
por: Kattner, Aila Akosua
Publicado: (2022)

Urge-tic associations in children and adolescents with Tourette syndrome
por: Langelage, Jennifer, et al.
Publicado: (2022)

Effects of Group Comprehensive Behavioral Intervention for Tics in Children With Tourette’s Disorder and Chronic Tic Disorder
por: Kang, Na Ri, et al.
Publicado: (2022)

Benign Presentation Following Massive Deutetrabenazine Overdose
por: Obadeyi, Oluseyi, et al.
Publicado: (2021)

Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering
por: Ha, Catherine A., et al.
Publicado: (2021)

European clinical guidelines for Tourette Syndrome and other tic disorders
por: Roessner, Veit, et al.
Publicado: (2011)

Handwriting Tics in Tourette’s Syndrome: A Single Center Study
por: Zanaboni Dina, Carlotta, et al.
Publicado: (2016)

Novel Psychological Formulation and Treatment of “Tic Attacks” in Tourette Syndrome
por: Robinson, Sally, et al.
Publicado: (2016)

Tic Exacerbation in Adults with Tourette Syndrome: A Case Series
por: Schaefer, Sara M., et al.
Publicado: (2017)

Oral splint ameliorates tic symptoms in patients with tourette syndrome
por: Murakami, Jumpei, et al.
Publicado: (2019)

Serious Transport Accidents in Tourette Syndrome or Chronic Tic Disorder
por: Mataix‐Cols, David, et al.
Publicado: (2020)

Association of Prenatal Maternal Anemia with Tics and Tourette’s Syndrome in Offspring
por: Liu, Yi-Chun, et al.
Publicado: (2021)

A clinical inventory of moderators of tic severity in Tourette's Syndrome
por: Conti, Francesca, et al.
Publicado: (2021)

Fractality of tics as a quantitative assessment tool for Tourette syndrome
por: Beeler, Payton, et al.
Publicado: (2022)

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis
por: Schneider, Frank, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fkvn0tvk56qblvi1prru7o2i4n